Robert E. Hoffman - 22 Jun 2021 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Marc Grasso, Attorney-in-fact for Robert Hoffman
Issuer symbol
KURA
Transactions as of
22 Jun 2021
Net transactions value
$0
Form type
4
Filing time
23 Jun 2021, 17:14:28 UTC
Next filing
22 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +23,000 $0.000000 23,000 22 Jun 2021 Common Stock 23,000 $21.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full on the one year anniversary of the date of grant.